Antimicrobial Activity of Selenium Nanoparticles (SeNPs) against Potentially Pathogenic Oral Microorganisms: A Scoping Review
- PMID: 37765222
- PMCID: PMC10537110
- DOI: 10.3390/pharmaceutics15092253
Antimicrobial Activity of Selenium Nanoparticles (SeNPs) against Potentially Pathogenic Oral Microorganisms: A Scoping Review
Abstract
Biofilms are responsible for the most prevalent oral infections such as caries, periodontal disease, and pulp and periapical lesions, which affect the quality of life of people. Antibiotics have been widely used to treat these conditions as therapeutic and prophylactic compounds. However, due to the emergence of microbial resistance to antibiotics, there is an urgent need to develop and evaluate new antimicrobial agents. This scoping review offers an extensive and detailed synthesis of the potential role of selenium nanoparticles (SeNPs) in combating oral pathogens responsible for causing infectious diseases. A systematic search was conducted up until May 2022, encompassing the MEDLINE, Embase, Scopus, and Lilacs databases. We included studies focused on evaluating the antimicrobial efficacy of SeNPs on planktonic and biofilm forms and their side effects in in vitro studies. The selection process and data extraction were carried out by two researchers independently. A qualitative synthesis of the results was performed. A total of twenty-two articles were considered eligible for this scoping review. Most of the studies reported relevant antimicrobial efficacy against C. albicans, S. mutans, E. faecalis, and P. gingivalis, as well as effective antioxidant activity and limited toxicity. Further research is mandatory to critically assess the effectiveness of this alternative treatment in ex vivo and in vivo settings, with detailed information about SeNPs concentrations employed, their physicochemical properties, and the experimental conditions to provide enough evidence to address the construction and development of well-designed and safe protocols.
Keywords: antimicrobial activity; biofilm; oral pathogens; planktonic state; selenium nanoparticles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Antimicrobial effects of selenium nanoparticles in combination with photodynamic therapy against Enterococcus faecalis biofilm.Photodiagnosis Photodyn Ther. 2021 Sep;35:102398. doi: 10.1016/j.pdpdt.2021.102398. Epub 2021 Jun 13. Photodiagnosis Photodyn Ther. 2021. PMID: 34133959
-
The application of selenium nanoparticles for enhancing the efficacy of photodynamic inactivation of planktonic communities and the biofilm of Streptococcus mutans.BMC Res Notes. 2022 Feb 24;15(1):84. doi: 10.1186/s13104-022-05973-w. BMC Res Notes. 2022. PMID: 35209935 Free PMC article.
-
Nanostructured biomedical selenium at the biological interface (Review).Biointerphases. 2018 Sep 21;13(6):06D301. doi: 10.1116/1.5042693. Biointerphases. 2018. PMID: 30241439 Review.
-
Functionalized Nanoparticles Activated by Photodynamic Therapy as an Antimicrobial Strategy in Endodontics: A Scoping Review.Antibiotics (Basel). 2021 Sep 2;10(9):1064. doi: 10.3390/antibiotics10091064. Antibiotics (Basel). 2021. PMID: 34572645 Free PMC article. Review.
Cited by
-
Transforming Medicine with Nanobiotechnology: Nanocarriers and Their Biomedical Applications.Pharmaceutics. 2024 Aug 23;16(9):1114. doi: 10.3390/pharmaceutics16091114. Pharmaceutics. 2024. PMID: 39339152 Free PMC article. Review.
References
-
- Dashper S.G., Nastri A., Abbott P.V. Odontogenic Bacterial Infections. In: Farah C., Balasubramaniam R., McCullough M., editors. Contemporary Oral Medicine. Springer; Cham, Switzerland: 2017.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources